Search for dissertations about: "Antibiotic prophylaxis"
Showing result 21 - 25 of 28 swedish dissertations containing the words Antibiotic prophylaxis.
-
21. Stress urinary incontinence among women. Aspects of risk factors, evaluation and surgical treatment
Abstract : The etiology of female stress urinary incontinence (SUI) is unclear. By linking three nationwide medical registries we evaluated maternal and obstetric factors associated with later SUI surgery. Surgery for SUI was strongly associated with vaginal delivery, but not with pregnancy as such. READ MORE
-
22. Molecular epidemiology of Staphylococcus epidermidis in prosthetic joint infections
Abstract : Staphylococcus epidermidis is ubiquitous in the human microbiota, but also an important pathogen in healthcare-associated infections, such as prosthetic joint infections (PJIs). In this thesis, aspects of the molecular epidemiology of S. READ MORE
-
23. Perioperative acute kidney injury : risk factors and outcomes
Abstract : Background: Acute kidney injury (AKI) is defined as a sudden decrease in renal filtration function. It is common among critically ill patients and patients undergoing major surgery, especially cardiac surgery. AKI is defined by either an elevated serum creatinine (SCr) concentration or a decrease in urine production. READ MORE
-
24. Urinary catheter policies for short-term bladder drainage in hip surgery patients
Abstract : The overall aim of this thesis was to evaluate methods for urinary catheter handling in patients undergoing hip surgery. The intention was to gain knowledge in order to provide optimal and cost- effective care regarding urinary catheterisation in this group of patients. READ MORE
-
25. Targeted CD52 therapy in lymphoid malignancies : a clinical and immunological study
Abstract : There is a great need for developing new treatment alternatives in low grade non Hodgkin's lymphoma (NHL) including chronic lymphocytic leukemia (CLL). The CD52 antigen, which is expressed on almost all lymphoid malignancies, can be utilized as a target for CD52-directed monoclonal antibody therapy (alemtuzumab, Campath-1 H). READ MORE